EMQN CIC launched a new Haemato-Oncology EQA category for the 2027 EQA Catalogue.
Published
Signal category
Products & Services
Quote
“This launch is particularly special as it introduces a brand-new chapter for EMQN with the launch of our new Haemato-Oncology EQA category.”
— EMQN CIC team
Company
EMQN CIC
Quality assurance tools and knowledge for molecular pathology and genetic testing
- Industry
- Hospitals and Health Care
- Location
- Manchester, GB
- Company size
- 44 employees
EMQN is the leading global provider of quality assurance tools and knowledge to the human molecular pathology and genetic testing community in the form of External Quality Assessment (EQA) schemes, also referred to as proficiency testing (PT). This assures the best possible clinical diagnostics test execution, accuracy, performance, interpretation, and reporting. Furthermore, EMQN’s highly qualified peer group of assessors take pride in their thought leadership position by their commitment to regularly publishing best practice guidelines. We believe that every patient should have the most accurate diagnostic test result possible. After all, many lives may depend on a correct diagnosis and appropriate treatment assessment. EMQN CIC is an incorporated Community Interest Company registered in England and Wales (Companies House Registration: 12020789). Our registered address: Third Floor, ICE Building, 3 Exchange Quay, Salford, M5 3ED
Founded 1997